Related Experiment Video
Updated: Aug 23, 2025

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
OUTPATIENT TREATMENT OF PULMONARY EMBOLISM - A SINGLE-CENTER EXPERIENCE
1Emergency Department, University Hospital Center Zagreb, Croatia.
Early discharge for low-risk pulmonary embolism (PE) patients is safe and effective. This approach reduces healthcare costs and improves hospital bed availability without increasing adverse events.
Area of Science:
- Emergency Medicine
- Cardiology
- Pulmonary Medicine
Background:
- Pulmonary embolism (PE) is a frequent emergency department diagnosis and cause of hospital admission.
- Risk stratification allows for early discharge of PE patients, optimizing hospital resources and reducing costs.
- Established protocols are crucial for managing PE, including risk assessment for adverse events and bleeding.
Purpose of the Study:
- To outline emergency department protocols for pulmonary embolism (PE) management.
- To emphasize risk stratification for adverse events and bleeding risk in PE patients.
- To detail treatment strategies and outcomes for PE patients managed under these protocols.
Main Methods:
- Retrospective analysis of patients diagnosed with low-risk pulmonary embolism (PE).
- Study period: two-year duration (2020-2021).
- Inclusion of 42 patients discharged within 24 hours or after short-term hospitalization.
Main Results:
- 91% of discharged PE patients received direct oral anticoagulants.
- No adverse events such as hemorrhage, PE progression, or major cardiovascular issues were observed.
- All included patients were discharged following a short observation period (<24 hours).
Conclusions:
- Early discharge and outpatient treatment for pulmonary embolism (PE) are safe and effective.
- This management strategy leads to reduced healthcare expenditures.
- The protocol resulted in a minimal incidence of adverse events in the patient cohort.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction
Venous Thrombosis III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...

